March 17 (Reuters) - Thirty five generic drugmakers around the world will make cheap versions of Pfizer Inc's highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback